Jefferies

Fierce Pharma

M&A surge triggers high expectations for 2026

A blitz of biopharma activity at the end of March indicates that 2026 will be a prime year for M&A and that the surge seen in Q4 was not a false alarm.

Kevin Dunleavy Apr 6, 2026 5:00am

JPM26: All of the meetings, none of the megadeals

Jan 15, 2026 4:30am

Global uncertainties can't dampen upbeat Jefferies conference

Nov 24, 2025 3:00am

Jefferies London conference earns reputation as 'JPM for Europe'

Nov 18, 2025 10:00am

Jefferies Healthcare Conference London 2024

The JPM pregame: Jam-packed Jefferies conference makes its mark

Nov 19, 2024 11:00am

Optimism at Jefferies, but don't expect IPO boost soon—Sofinnova

Nov 16, 2023 3:00am